Therapeutic Targeting of PPARγ in Nonalcoholic Fatty Liver Disease: Efficacy, Safety, and Drug Development
Zhanyi Zhou,1,* Rijuan Jin,1,* Yuting Gu,1 Yunxi Ji,2 Yijie Lou,1 Jianbing Wu3 1The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People’s Republic of China; 2Department of General Practice, Zhejiang Provincial Hospital of Traditi...
Saved in:
| Main Authors: | Zhou Z, Jin R, Gu Y, Ji Y, Lou Y, Wu J |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-08-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/therapeutic-targeting-of-ppar-in-nonalcoholic-fatty-liver-disease-effi-peer-reviewed-fulltext-article-DDDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AuNRs-PPARγmAb Induce Targeted Adipocyte Apoptosis Through Photothermal Effects for Effective Localized Fat Reduction
by: Hu Y, et al.
Published: (2025-08-01) -
Investigating the Role and Underlying Mechanisms of 18β-Glycyrrhetinic Acid in the Therapy of Ulcerative Colitis Through Modulation of the PPAR-γ/NF-κB Signaling Pathway
by: Zhu A, et al.
Published: (2025-06-01) -
PPAR-γ in Melanoma and Immune Cells: Insights into Disease Pathogenesis and Therapeutic Implications
by: Vladimir Sobolev, et al.
Published: (2025-04-01) -
PPARγ-SMAD6 axis-mediated inhibition of osteogenic differentiation is involved in BPS-induced osteoporosis
by: Zhenkun Weng, et al.
Published: (2025-04-01) -
Evaluation of C-X-C chemokine receptor type 4 (CXCR4) and Peroxisome proliferator-activated receptor gamma (PPAR-γ) expression in colorectal carcinoma: Relation to the available clinicopathological parameters
by: Asmaa E. Bedeer, et al.
Published: (2023-07-01)